In an interview with Pharmacy Times, Thomas Lodise, PharmD, PhD, discussed new guidance released by the Infectious Diseases Society of America (IDSA) on the treatment of antimicrobial resistant gram-negative infections. The guidelines were reviewed...
Recent findings Treatment of severe infections caused by nonfermenting gram-negative bacteria (NF-GNB) is posing both novel hopes and novel challenges to physicians worldwide, and both the IDSA and the ESCMID have recently updated/released their guidelines or guidance documents, based on different ...
IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections Clinical Microbiology and Infection, Volume 28, Issue 4, April 2022, Pages 465-469 Alexander Lawandi, Christina Yek, Sameer S. KadriView PDFAbstract Scope These ESCMID guidelines addres...
IDSA guidance on the treatment of antimicrobial-resistant gram-negative infections: version 1.0. A Focus on extended-spectrum β-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and pseudomonas aeruginosa with difficult-to-treat resistance (DTRP. aeruginosa). ...
European Society of Clinical Microbiol‑ ogy and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521–47. 20. Wang J, Pan Y,...
Shorter courses of antimicrobial therapy have been shown to be non-inferior to longer durations for the management of several infections. However, data on critically ill patients with severe infections by multidrug-resistant Gram-negative bacteria (MDR-G
www.ccmjournal.org Critical Care Medicine Volume 46 Number 1 (Supplement) Learning Objectives: The IDSA guidelines recommend double gram-negative (GN) coverage for pneumonia when patients have risk factors for resistance, or are in a unit with > 10% GN isolates resistant to the primary...
There are also different treatment guidelines for infections caused by these microorganisms that have been approved by different professional societies, including those of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Disease Society of Am...
357: EVALUATION OF EMPIRIC SINGLE COVERAGE GRAM-NEGATIVE VENTILATOR ASSOCIATED PNEUMONIA PROTOCOL IN AN ACADEMIC LEVEL ONE TRAUMA/SURGICAL INTENSIVE CARE UNITdoi:10.1097/01.ccm.0000424575.62284.1eIntroduction: The 2005 ATS/IDSA guidelines for ventilator associated pneumonia (VAP), a subset of hoKim, ...
The latest Infectious Diseases Society of America (IDSA) guidelines for empirical antimicrobial therapy only recommend routine coverage for Gram-positive bacteria, whereas coverage for Gram-negative microorganisms is reserved for certain circumstances (critically ill or neutropenic patients, those with a ...